<DOC>
	<DOCNO>NCT01223157</DOCNO>
	<brief_summary>Up till , evaluation endocannabinoid system ( ECS ) humans needs invasive procedure . The investigator manage lab determine level endocannabinoids small number subject . The aim study confirm salivary useful tool evaluate activity ECS normal weight obese subject characterise hyperactivity system . Therefore , first objective study compare fast level salivary anandamide 12 obese patient 12 normal weight subject .</brief_summary>
	<brief_title>Saliva Plasma Endocannabinoids Concentrations According Feeding Status Body Mass Index</brief_title>
	<detailed_description>The prevalence obesity keep increase industrialized country . However , efficient treatment chronic disease still lack . A good understanding system regulate energy balance eat behavior mandatory good understand disease find appropriate treatment . The endocannabinoid system ( ECS ) comprise cannabinoid receptor , CB1 CB2 , endogenous ligand ( name endocannabinoids ) specific biosynthetic degradative pathway key system regulation energy balance obesity . Obesity characterise hyperactivity system animal human . Moreover , activity ECS influence feed status although one study perform human . The investigation ECS humans need invasive procedure ( blood sample adipose liver biopsy ) . The aim study evaluate new tool ECS evaluation human e determination saliva concentration endocannabinoids normal weight obese subject food intake . Blood saliva sample perform overnight fast , one hour , one hour lunch in12 normal weight subject 12 obese characterise anthropometric ( Weight , height , BMI ( Body Mass Index ) , waist circumference , blood pressure ) metabolic ( glycaemia , insulin , lipid profile , liver profile ) evaluation . The endocannabinoids concentration measure mass spectrometry blood saliva gut hormone ( PYY ( peptide YY ) ghrelin ) measure plasma .</detailed_description>
	<criteria>Obese patient : Age 18 65 yr BMI ( Body Mass Index ) &gt; 30 kg/m² Signed inform Consent investigation relate study No smoker Normal weight subject : Age 18 65 yr BMI 18 25 kg/m² Signed inform Consent investigation relate study No smoker treatment could interfere endocannabinoid system ( anxiolytic , anticonvulsivants , antidepressant drug ) pregnancy , breast feeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2011</verification_date>
	<keyword>obesity</keyword>
	<keyword>endocannabinoids</keyword>
</DOC>